Administration of Hypoxia-Activated Prodrug Evofosfamide after Conventional Adjuvant Therapy Enhances Therapeutic Outcome and Targets Cancer-Initiating Cells in Preclinical Models of Colorectal Cancer
Haynes, Jennifer, McKee, Trevor D, Haller, Andrew, Wang, Yadong, Leung, Cherry, Gendoo, Deena M A, Lima-Fernandes, Evelyne, Kreso, Antonija, Wolman, Robin, Szentgyorgyi, Eva, Vines, Douglass C, Haibe-Kains, Benjamin, Wouters, Bradly G, Metser, Ur, Jaffray, David A, Smith, Myles, O'Brien, Catherine A
Published in Clinical cancer research (01.05.2018)
Published in Clinical cancer research (01.05.2018)
Get full text
Journal Article